Study sheds new light on transplant, cancer link

Posted on 2008-07-15 20:00:00 in Artificial & Replacement Organs & Tissues | Cancer | Immune System | Surgery |

Targeted therapies in patients who have undergone organ transplantation could help reduce risk of cancer, new findings suggest.

Researchers at Harvard Medical School have discovered that the immunosuppressant drug cyclosporine can often lead to cancer by enabling the growth of new tumor-feeding blood cells.

Figures show that 15 to 20 per cent of transplant patients develop cancer within ten years of the surgery.

Senior investigator, Dr Soumitro Pal, an assistant professor at Harvard Medical School's Transplantation Research Center at Children's Hospital in Boston, explained: "Once the organ has stabilized, it may be possible to lower the level of vascular endothelial growth factor expression to prevent tumor growth. We would need to figure out how to balance benefit and risk to keep cancer at bay."

Dr Pal added: "It is likely not the whole story, but this gives us a clue that we might be able to use existing or novel therapies to reduce cancer risk in transplanted patients."

The study, published in the latest issue of Cancer Research, was carried out in animal and laboratory experiments.ADNFCR-1506-ID-18687490-ADNFCR


Health Headlines

Gut Bacteria May Promote Weight Gain
In a lab animal model, booming gut flora spawned by the Western diet is linked to obesity.
Reduce Income Inequalities to Save Millions of Lives and Improve Quality of Life
International study reaffirms importance of resolving the income gap between the richest and poorest people in developed countries.
Chocolate May Slash Stress
Switzerland-based research team assesses the metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress hormones.
Among Youngest Older Americans, Disability on the Rise
UCLA researchers find disability rates in Americans entering their 60s are on the rise, potentially fueled by the overweight/obesity epidemic.
Living to 100 Linked to Variant of Telomere Enzyme
Genetic clues to longevity discovered among a homogenous ethnic population.
Keep Muscles Strong to Slash Risk of Cognitive Decline
Rush Alzheimer's Disease Center (USA) researchers find that a loss of muscle strength raises risk of Alzheimer’s Disease and mild cognitive impairment.
Cumulative Exposure to Common Infections May Raise Risk of Stroke
Stroke risk may rise in those with common infectious pathogens such as Chlamydia pneumoniae, Helicobacter pylori, and herpes simplex viruses.
Chemical Present in Plastic Bottles, Canned Products Linked to Male Reproductive Problems
First study in humans links bisphenol A (BPA) exposure to male sexual function problems.
Promote Walking to Encourage Healthy Habits
Simple steps in the community can promote walking among residents.
Poor Leadership at Work Can Make Employees Sick
Study finds that people who are dissatisfied with their workplace bosses not only take more sick leave, but are at increased risk of suffering a heart attack.
Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Las Vegas
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010

VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health (PATH Medical), Chairs the Brain Age Workshop taking place Dec. 9, 2009. Held in conjunction with the Winter Session of the 17th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies. The Brain Age Workshop features presentations on Brain Mind Assessment via Neuropsychological Analysis, Movement Deficiency Syndrome, Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain Injury. View this video to learn about Dr. Braverman’s brain-based model of aging and age modulation.

International Events
See all events »